关注
Michela Antonucci
Michela Antonucci
在 unipa.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Multimodal approaches to the treatment of hepatocellular carcinoma
G Cabibbo, F Latteri, M Antonucci, A Craxì
Nature Reviews Gastroenterology & Hepatology 6 (3), 159-169, 2009
1162009
Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study
G Cabibbo, M Maida, C Genco, P Parisi, M Peralta, M Antonucci, ...
World journal of hepatology 4 (9), 256, 2012
1022012
Causes of and prevention strategies for hepatocellular carcinoma
G Cabibbo, M Maida, C Genco, M Antonucci, C Cammà
Seminars in oncology 39 (4), 374-383, 2012
642012
AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD
G Pennisi, M Enea, A Pandolfo, C Celsa, M Antonucci, C Ciccioli, ...
Clinical Gastroenterology and Hepatology 21 (5), 1293-1302. e5, 2023
502023
Transarterial chemoembolization and sorafenib in hepatocellular carcinoma
G Cabibbo, S Tremosini, G Galati, G Mazza, G Gadaleta-Caldarola, ...
Expert review of anticancer therapy 14 (7), 831-845, 2014
242014
Curative therapies for hepatocellular carcinoma: an update and perspectives
R Sacco, M Antonucci, G Bresci, A Corti, L Giacomelli, V Mismas, ...
Expert review of anticancer therapy 16 (2), 169-175, 2016
132016
Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
R Sacco, M Antonucci, I Bargellini, S Marceglia, V Mismas, G Cabibbo
Future Oncology 11 (17), 2371-2373, 2015
132015
Update on new approaches in the management of hepatocellular carcinoma
G Cabibbo, M Antonucci, C Genco
Hepatic Medicine: Evidence and Research, 163-173, 2010
92010
Minor hepatic resection for hepatocellular carcinoma in cirrhotic patients: kelly clamp crushing resection versus heat coagulative necrosis with bipolar radiofrequency device
L Sandonato, M Soresi, C Cipolla, TV Bartolotta, L Giannitrapani, ...
The American Surgeon 77 (11), 1490-1495, 2011
82011
Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively …
M Pavlides, FE Mózes, S Akhtar, K Wonders, J Cobbold, EM Tunnicliffe, ...
Contemporary clinical trials 134, 107352, 2023
62023
Balancing efficacy and tolerability of first-line systemic therapies for advanced hepatocellular carcinoma: a network metanalysis
C Celsa, G Cabibbo, DJ Pinato, G Maria, M Enea, M Vaccaro
Liver Cancer 10, 000531744, 2023
52023
The evolving scenario in the assessment of radiological response for hepatocellular carcinoma in the era of immunotherapy: Strengths and weaknesses of surrogate endpoints
P Giuffrida, C Celsa, M Antonucci, M Peri, MV Grassini, G Rancatore, ...
Biomedicines 10 (11), 2827, 2022
42022
Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?
G Cabibbo, M Antonucci, R Sacco, E Sciarrino
Expert Review of Anticancer Therapy 15 (2), 147-150, 2015
32015
LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
R Cannella, F Vernuccio, M Antonucci, DS Gagliano, F Matteini, M Midiri, ...
European Radiology, 1-9, 2022
22022
Role of radiomics in predicting biological aggressiveness and prognosis of pancreatic adenocarcinoma
M Antonucci
Università degli Studi di Palermo, 2024
2024
T. 07.7: CHARACTERISTICS AND MANAGEMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN SICILY: FIRST RESULTS OF THE HCC SICILY MULTIDISCIPLINARY NETWORK
C Celsa, G Cabibbo, R Ciccia, G Di Maria, D Pagano, R Miraglia, ...
Digestive and Liver Disease 56, S258, 2024
2024
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network
C Celsa, G Cabibbo, R Ciccia, G Di Maria, D Pagano, R Miraglia, ...
Digestive and Liver Disease 56, S83-S84, 2024
2024
Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?
C Celsa, G Cabibbo, GEM Rizzo, P Giuffrida, M Enea, G Di Maria, ...
Digestive and Liver Disease 55, S3, 2023
2023
Abdominal manifestations of COVID-19: Radiologic overwiew
F MATTEINI, R Cannella, F Vernuccio, M Antonucci, L Tesè, M Midiri, ...
European Congress of Radiology-ECR 2022, 2022
2022
Diagnostic performance of AGILE 3+ score for identification of advanced fibrosis and prediction of liver-related events in patients with non-alcoholic fatty liver disease
G Pennisi, C Celsa, M Enea, A Pandolfo, M Antonucci, C Ciccioli, ...
Journal of Hepatology 77, S448, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20